Cargando…

Echocardiographic assessment of insulin‐like growth factor binding protein‐7 and early identification of acute heart failure

AIMS: Concentrations of insulin‐like growth factor binding protein‐7 (IGFBP7) have been linked to abnormal cardiac structure and function in patients with chronic heart failure (HF), but cardiovascular correlates of the biomarker in patients with more acute presentations are lacking. We aimed to det...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalayci, Arzu, Peacock, W. Frank, Nagurney, John T., Hollander, Judd E., Levy, Phillip D., Singer, Adam J., Shapiro, Nathan I., Cheng, Richard K., Cannon, Chad M., Blomkalns, Andra L., Walters, Elizabeth L., Christenson, Robert H., Chen‐Tournoux, Annabel, Nowak, Richard M., Lurie, Mark D., Pang, Peter S., Kastner, Peter, Masson, Serge, Gibson, C. Michael, Gaggin, Hanna K., Januzzi Jr, James L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373911/
https://www.ncbi.nlm.nih.gov/pubmed/32406612
http://dx.doi.org/10.1002/ehf2.12722
_version_ 1783561586771755008
author Kalayci, Arzu
Peacock, W. Frank
Nagurney, John T.
Hollander, Judd E.
Levy, Phillip D.
Singer, Adam J.
Shapiro, Nathan I.
Cheng, Richard K.
Cannon, Chad M.
Blomkalns, Andra L.
Walters, Elizabeth L.
Christenson, Robert H.
Chen‐Tournoux, Annabel
Nowak, Richard M.
Lurie, Mark D.
Pang, Peter S.
Kastner, Peter
Masson, Serge
Gibson, C. Michael
Gaggin, Hanna K.
Januzzi Jr, James L.
author_facet Kalayci, Arzu
Peacock, W. Frank
Nagurney, John T.
Hollander, Judd E.
Levy, Phillip D.
Singer, Adam J.
Shapiro, Nathan I.
Cheng, Richard K.
Cannon, Chad M.
Blomkalns, Andra L.
Walters, Elizabeth L.
Christenson, Robert H.
Chen‐Tournoux, Annabel
Nowak, Richard M.
Lurie, Mark D.
Pang, Peter S.
Kastner, Peter
Masson, Serge
Gibson, C. Michael
Gaggin, Hanna K.
Januzzi Jr, James L.
author_sort Kalayci, Arzu
collection PubMed
description AIMS: Concentrations of insulin‐like growth factor binding protein‐7 (IGFBP7) have been linked to abnormal cardiac structure and function in patients with chronic heart failure (HF), but cardiovascular correlates of the biomarker in patients with more acute presentations are lacking. We aimed to determine the relationship between IGFBP7 concentrations and cardiac structure and to evaluate the impact of IGFBP7 on the diagnosis of acute HF among patients with acute dyspnoea. METHODS AND RESULTS: In this pre‐specified subgroup analysis of the International Collaborative of N‐terminal pro‐B‐type Natriuretic Peptide Re‐evaluation of Acute Diagnostic Cut‐Offs in the Emergency Department (ICON‐RELOADED) study, we included 271 patients with and without acute HF. All patients presented to an emergency department with acute dyspnoea, had blood samples for IGFBP7 measurement, and detailed echocardiographic evaluation. Higher IGFBP7 concentrations were associated with numerous cardiac abnormalities, including increased left atrial volume index (LAVi; r = 0.49, P < 0.001), lower left ventricular ejection fraction (r = −0.27, P < 0.001), lower right ventricular fractional area change (r = −0.31, P < 0.001), and higher tissue Doppler E/e′ ratio (r = 0.44, P < 0.001). In multivariable linear regression analyses, increased LAVi (P = 0.01), lower estimated glomerular filtration rate (P = 0.008), higher body mass index (P = 0.001), diabetes (P = 0.009), and higher concentrations of amino‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP, P = 0.02) were independently associated with higher IGFBP7 concentrations regardless of other variables. Furthermore, IGFBP7 (odds ratio = 12.08, 95% confidence interval 2.42–60.15, P = 0.02) was found to be independently associated with the diagnosis of acute HF in the multivariable logistic regression analysis. CONCLUSIONS: Among acute dyspnoeic patients with and without acute HF, increased IGFBP7 concentrations are associated with a range of cardiac structure and function abnormalities. Independent association with increased LAVi suggests elevated left ventricular filling pressure is an important trigger for IGFBP7 expression and release. IGFBP7 may enhance the diagnosis of acute HF.
format Online
Article
Text
id pubmed-7373911
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73739112020-07-22 Echocardiographic assessment of insulin‐like growth factor binding protein‐7 and early identification of acute heart failure Kalayci, Arzu Peacock, W. Frank Nagurney, John T. Hollander, Judd E. Levy, Phillip D. Singer, Adam J. Shapiro, Nathan I. Cheng, Richard K. Cannon, Chad M. Blomkalns, Andra L. Walters, Elizabeth L. Christenson, Robert H. Chen‐Tournoux, Annabel Nowak, Richard M. Lurie, Mark D. Pang, Peter S. Kastner, Peter Masson, Serge Gibson, C. Michael Gaggin, Hanna K. Januzzi Jr, James L. ESC Heart Fail Original Research Articles AIMS: Concentrations of insulin‐like growth factor binding protein‐7 (IGFBP7) have been linked to abnormal cardiac structure and function in patients with chronic heart failure (HF), but cardiovascular correlates of the biomarker in patients with more acute presentations are lacking. We aimed to determine the relationship between IGFBP7 concentrations and cardiac structure and to evaluate the impact of IGFBP7 on the diagnosis of acute HF among patients with acute dyspnoea. METHODS AND RESULTS: In this pre‐specified subgroup analysis of the International Collaborative of N‐terminal pro‐B‐type Natriuretic Peptide Re‐evaluation of Acute Diagnostic Cut‐Offs in the Emergency Department (ICON‐RELOADED) study, we included 271 patients with and without acute HF. All patients presented to an emergency department with acute dyspnoea, had blood samples for IGFBP7 measurement, and detailed echocardiographic evaluation. Higher IGFBP7 concentrations were associated with numerous cardiac abnormalities, including increased left atrial volume index (LAVi; r = 0.49, P < 0.001), lower left ventricular ejection fraction (r = −0.27, P < 0.001), lower right ventricular fractional area change (r = −0.31, P < 0.001), and higher tissue Doppler E/e′ ratio (r = 0.44, P < 0.001). In multivariable linear regression analyses, increased LAVi (P = 0.01), lower estimated glomerular filtration rate (P = 0.008), higher body mass index (P = 0.001), diabetes (P = 0.009), and higher concentrations of amino‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP, P = 0.02) were independently associated with higher IGFBP7 concentrations regardless of other variables. Furthermore, IGFBP7 (odds ratio = 12.08, 95% confidence interval 2.42–60.15, P = 0.02) was found to be independently associated with the diagnosis of acute HF in the multivariable logistic regression analysis. CONCLUSIONS: Among acute dyspnoeic patients with and without acute HF, increased IGFBP7 concentrations are associated with a range of cardiac structure and function abnormalities. Independent association with increased LAVi suggests elevated left ventricular filling pressure is an important trigger for IGFBP7 expression and release. IGFBP7 may enhance the diagnosis of acute HF. John Wiley and Sons Inc. 2020-05-14 /pmc/articles/PMC7373911/ /pubmed/32406612 http://dx.doi.org/10.1002/ehf2.12722 Text en © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research Articles
Kalayci, Arzu
Peacock, W. Frank
Nagurney, John T.
Hollander, Judd E.
Levy, Phillip D.
Singer, Adam J.
Shapiro, Nathan I.
Cheng, Richard K.
Cannon, Chad M.
Blomkalns, Andra L.
Walters, Elizabeth L.
Christenson, Robert H.
Chen‐Tournoux, Annabel
Nowak, Richard M.
Lurie, Mark D.
Pang, Peter S.
Kastner, Peter
Masson, Serge
Gibson, C. Michael
Gaggin, Hanna K.
Januzzi Jr, James L.
Echocardiographic assessment of insulin‐like growth factor binding protein‐7 and early identification of acute heart failure
title Echocardiographic assessment of insulin‐like growth factor binding protein‐7 and early identification of acute heart failure
title_full Echocardiographic assessment of insulin‐like growth factor binding protein‐7 and early identification of acute heart failure
title_fullStr Echocardiographic assessment of insulin‐like growth factor binding protein‐7 and early identification of acute heart failure
title_full_unstemmed Echocardiographic assessment of insulin‐like growth factor binding protein‐7 and early identification of acute heart failure
title_short Echocardiographic assessment of insulin‐like growth factor binding protein‐7 and early identification of acute heart failure
title_sort echocardiographic assessment of insulin‐like growth factor binding protein‐7 and early identification of acute heart failure
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373911/
https://www.ncbi.nlm.nih.gov/pubmed/32406612
http://dx.doi.org/10.1002/ehf2.12722
work_keys_str_mv AT kalayciarzu echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT peacockwfrank echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT nagurneyjohnt echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT hollanderjudde echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT levyphillipd echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT singeradamj echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT shapironathani echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT chengrichardk echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT cannonchadm echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT blomkalnsandral echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT walterselizabethl echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT christensonroberth echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT chentournouxannabel echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT nowakrichardm echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT luriemarkd echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT pangpeters echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT kastnerpeter echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT massonserge echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT gibsoncmichael echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT gagginhannak echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure
AT januzzijrjamesl echocardiographicassessmentofinsulinlikegrowthfactorbindingprotein7andearlyidentificationofacuteheartfailure